# A Trial of Hetrombopag in Healthy Subjects

> **NCT05088174** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 26 (actual)

## Conditions studied

- Sever Aplastic Anaemia

## Interventions

- **DRUG:** Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule

## Key facts

- **NCT ID:** NCT05088174
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-03
- **Primary completion:** 2020-10-22
- **Final completion:** 2020-10-22
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088174, "A Trial of Hetrombopag in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05088174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*